Current trends in gingival recession coverage--Part II: Enamel matrix derivative and platelet-rich plasma.
The recession of the gingiva is increasingly becoming a prominent condition in the oral health of many patients and should be treated at its earliest detection. Part I of this discussion reviewed the multifactorial etiology and decision modality; a treatment option was demonstrated for gingival recession using the tunneling technique. This concluding part of the discussion highlights two clinical cases using alternative approaches. The correction of Class I and II gingival recessions are presented as a means of minimizing surgical trauma and achieving predictable aesthetic results.
Saadoun
André P
AP
andre.p.saadoun@wanadoo.fr
D000328:Adult; D003238:Connective Tissue / Q000637:transplantation; D003746:Dental Enamel Proteins / Q000494:pharmacology*; D003807:Dentin Sensitivity / Q000209:etiology / Q000601:surgery; D005260:Female; D005889:Gingival Recession / Q000150:complications / Q000601:surgery*; D005893:Gingivoplasty / Q000379:methods*; D016557:Guided Tissue Regeneration, Periodontal / Q000379:methods; D006801:Humans; D008297:Male; D008567:Membranes, Artificial; D008875:Middle Aged; D010519:Periodontium / Q000502:physiology; D053657:Platelet-Rich Plasma / Q000502:physiology; D012038:Regeneration / Q000187:drug effects*; D013524:Surgical Flaps
D003746:Dental Enamel Proteins; D008567:Membranes, Artificial; C109069:enamel matrix proteins